CME Group Inc. (NASDAQ:CME) Shares Purchased by Comprehensive Financial Consultants Institutional Inc.

Comprehensive Financial Consultants Institutional Inc. boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,288 shares of the financial services provider’s stock after purchasing an additional 547 shares during the period. CME Group comprises approximately 1.5% of Comprehensive Financial Consultants Institutional Inc.’s investment portfolio, making the stock its 18th biggest holding. Comprehensive Financial Consultants Institutional Inc.’s holdings in CME Group were worth $4,035,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Capital International Investors boosted its position in CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. lifted its stake in shares of CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the period. M&G Plc purchased a new stake in CME Group during the first quarter worth $156,631,000. Assenagon Asset Management S.A. grew its position in CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after buying an additional 550,133 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,621 shares of company stock worth $3,441,063. Insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.4 %

CME opened at $222.04 on Friday. The firm has a market capitalization of $79.96 billion, a price-to-earnings ratio of 23.35, a price-to-earnings-growth ratio of 5.61 and a beta of 0.55. The company’s 50 day simple moving average is $221.36 and its two-hundred day simple moving average is $209.75. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company posted $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.07%. CME Group’s dividend payout ratio is currently 48.37%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CME shares. Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. TD Cowen initiated coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. JPMorgan Chase & Co. increased their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Bank of America boosted their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Finally, Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.